Davis Capital Management Alkermes Plc. Transaction History
Davis Capital Management
- $123 Billion
- Q4 2024
A detailed history of Davis Capital Management transactions in Alkermes Plc. stock. As of the latest transaction made, Davis Capital Management holds 203 shares of ALKS stock, worth $7,153. This represents 0.0% of its overall portfolio holdings.
Number of Shares
203
Previous 203
-0.0%
Holding current value
$7,153
Previous $5.68 Million
2.75%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ALKS
# of Institutions
376Shares Held
173MCall Options Held
231KPut Options Held
158K-
Black Rock Inc. New York, NY29.1MShares$1.03 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$652 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$432 Million0.04% of portfolio
-
State Street Corp Boston, MA8.81MShares$311 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.56MShares$266 Million3.55% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.79B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...